Home  >  Companies  >  Alloy Therapeutics Alloy Therapeutics Follow Drug discovery platform and services for antibody, TCR mimic, and oligonucleotide therapeutics #biotechnology Valuation $1.00B 2026 Funding $136.24M 2022 Details Headquarters Boston, United States CEO Errik Anderson Website alloytx.com Milestones FOUNDING YEAR 2017 Listed In #biotechnology Alloy Therapeutics Overview Metrics News Filings News The latest coverage and announcements from Alloy Therapeutics. Try again